- ISIN
- CA0717341071
- CUSIP
- 071734107
- Sector
- Healthcare
- IPO Date
- Mar 29, 1994
Highlights
- Market Cap
- $2.57B
- Enterprise Value
- $1.67B
- EPS (TTM)
- -$3.87
- Total Revenue (TTM)
- $10.80B
- Gross Profit (TTM)
- $7.78B
- EBITDA (TTM)
- $1.78B
- Year Range
- $4.33 - $8.69
- Target Price
- $9.83
- ROA (TTM)
- -120.22%
- Avg. Volume (1M)
- 4M
- Avg. Volume Value (1M)
- $20.89M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
BHC Performance Chart
Bausch Health Companies Inc. (BHC) is down 0.9% since the beginning of the year. At $7 per share, BHC is trading 20.7% below its 52-week high of $9. Investors who bought $1,000 worth of BHC shares 5 years ago would now be looking at an investment worth $236.
Loading charts...
Compare this symbol against anything
Returns By Period
Bausch Health Companies Inc. (BHC) has returned -0.86% so far this year and 20.67% over the past 12 months. Over the last ten years, BHC has returned -10.62% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.
Bausch Health Companies Inc.
- 1D
- 14.26%
- 1M
- 40.61%
- 6M
- 20.03%
- YTD
- -0.86%
- 1Y
- 20.67%
- 3Y*
- -10.06%
- 5Y*
- -25.11%
- 10Y*
- -10.62%
- ALL TIME*
- -4.87%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
BHC Monthly Returns History
Based on dividend-adjusted daily data since Jan 2, 2001, BHC's average daily return is +0.04%, while the average monthly return is +0.81%. At this rate, an investment would double in approximately 7.2 years.
Historically, 53% of months were positive and 47% were negative. The best month was Jun 2025 with a return of +47.0%, while the worst month was Mar 2016 at -60.0%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 7 months.
On a daily basis, BHC closed higher 49% of trading days. The best single day was Nov 1, 2016 with a return of +33.7%, while the worst single day was Mar 15, 2016 at -51.5%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -17.41% | 3.31% | -8.94% | 5.93% | -6.29% | -8.02% | 39.76% | -0.86% | |||||
| 2025 | -7.82% | 0.13% | -13.04% | -18.08% | -14.53% | 47.02% | -11.56% | 25.98% | -13.07% | 8.84% | -9.54% | 9.45% | -13.77% |
| 2024 | -2.12% | 19.62% | 12.99% | -17.44% | -25.11% | 6.25% | -13.49% | -1.66% | 37.61% | 12.75% | -9.02% | -3.70% | 0.50% |
| 2023 | 22.61% | 20.91% | -13.00% | -9.01% | 11.40% | -2.56% | 21.38% | -14.11% | -1.44% | -17.03% | 4.69% | 12.32% | 27.71% |
| 2022 | -11.01% | -2.08% | -5.03% | -16.81% | -48.87% | -13.99% | -44.74% | 29.22% | 15.41% | -5.66% | 8.15% | -10.67% | -77.25% |
| 2021 | 22.60% | 23.22% | 1.02% | 1.35% | -0.03% | -8.83% | -0.24% | -0.41% | -4.39% | 0.83% | -15.10% | 15.81% | 32.74% |
Benchmark Metrics
Bausch Health Companies Inc. has an annualized alpha of 0.98%, beta of 1.03, and R2 of 0.14 versus S&P 500 Index. Calculated based on daily prices since January 02, 2001.
- This stock participated in 117.46% of S&P 500 Index downside but only 63.24% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.14 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 0.98%
- Beta
- 1.03
- R²
- 0.14
- Upside Capture
- 63.24%
- Downside Capture
- 117.46%
Return for Risk
Risk / Return Rank
BHC ranks 55 for risk / return — above 55% of stocks peers on PortfoliosLab. Its historical combined result is near the middle of the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Bausch Health Companies Inc. (BHC) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BHC | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.12 | ||
| Sortino ratioReturn per unit of downside risk | -0.98 | ||
| Omega ratioGain probability vs. loss probability | 1.11 | 1.25 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | 0.36 | 2.00 | -1.64 |
| Martin ratioReturn relative to average drawdown | 0.59 | 8.49 | -7.90 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Bausch Health Companies Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Bausch Health Companies Inc. was 98.35%, occurring on Apr 11, 2025. The portfolio has not yet recovered.
The current Bausch Health Companies Inc. drawdown is 97.38%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-98.35%Apr 2025 | 9y 8mo | — | 10y 12moAug 2015 - now | 2025 selloff2025 |
-82.32%Oct 2008 | 6y 9mo | 2y 3mo | 9y 26dJan 2002 - Jan 2011 | Financial crisis2007–2009 |
-40.33%Oct 2011 | 2mo 14d | 11mo 6d | 1y 1moJul 2011 - Sep 2012 | — |
-35.86%Apr 2001 | 1mo 3d | 3mo 25d | 4mo 28dMar 2001 - Jul 2001 | Dot-com crash2000–2002 |
-27.89%Aug 2014 | 5mo 10d | 5mo 4d | 10mo 14dFeb 2014 - Jan 2015 | — |
Drawdown Indicators
| BHC | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.35% | -56.78% | -41.57% |
Max Drawdown (1Y)Largest decline over 1 year | -46.88% | -9.10% | -37.78% |
Max Drawdown (3Y)Largest decline over 3 years | -59.28% | -18.90% | -40.38% |
Max Drawdown (5Y)Largest decline over 5 years | -85.34% | -25.43% | -59.91% |
Max Drawdown (10Y)Largest decline over 10 years | -87.43% | -33.92% | -53.51% |
Current DrawdownCurrent decline from peak | -97.38% | -1.58% | -95.80% |
Average DrawdownAverage peak-to-trough decline | -61.09% | -10.70% | -50.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.88% | 2.14% | +26.74% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Bausch Health Companies Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Bausch Health Companies Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for BHC relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, BHC has a P/S ratio of 0.2. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with BHC
Add Bausch Health Companies Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with BHC